BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 3308467)

  • 1. Partial ornithine transcarbamylase deficiency in females: diagnosis by an immunohistochemical method.
    Hayasaka K; Metoki K; Ishiguro S; Kato S; Chiba T; Hirooka M; Kikuchi M; Kurobane I; Narisawa K; Tada K
    Eur J Pediatr; 1987 Jul; 146(4):370-2. PubMed ID: 3308467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ornithine transcarbamylase deficiency in females: an often overlooked cause of treatable encephalopathy.
    Pridmore CL; Clarke JT; Blaser S
    J Child Neurol; 1995 Sep; 10(5):369-74. PubMed ID: 7499756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carnitine deficiency associated with ornithine transcarbamylase deficiency.
    Mayatepek E; Kurczynski TW; Hoppel CL; Gunning WT
    Pediatr Neurol; 1991; 7(3):196-9. PubMed ID: 1908679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of serious illness in heterozygotes for ornithine transcarbamylase deficiency.
    Batshaw ML; Msall M; Beaudet AL; Trojak J
    J Pediatr; 1986 Feb; 108(2):236-41. PubMed ID: 3944708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Genetic counseling in ornithine carbamoyltransferase deficiency].
    Pelet A; Toumas E; Rabier D; Kaplan J; Kamoun P; Frezal J; Saudubray JM; Munnich A
    Ann Biol Clin (Paris); 1988; 46(7):455-9. PubMed ID: 2903704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ornithine transcarbamylase (OTC) deficiency in a female patient with a de nova deletion of the paternal X chromosome.
    Slomski R; Braulke I; Behrend C; Schröder E; Colombo JP; Reiss J
    Hum Genet; 1992 Aug; 89(6):632-4. PubMed ID: 1511981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Site specific screening for point mutations in ornithine transcarbamylase deficiency.
    Feldmann D; Rozet JM; Pelet A; Hentzen D; Briand P; Hubert P; Largilliere C; Rabier D; Farriaux JP; Munnich A
    J Med Genet; 1992 Jul; 29(7):471-5. PubMed ID: 1353535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-strand conformational polymorphism and direct sequencing applied to carrier testing in families with ornithine transcarbamylase deficiency.
    Tsai MY; Holzknecht RA; Tuchman M
    Hum Genet; 1993 May; 91(4):321-5. PubMed ID: 8099056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fatal hyperammonemia resulting from a C-to-T mutation at a MspI site of the ornithine transcarbamylase gene.
    Hentzen D; Pelet A; Feldman D; Rabier D; Berthelot J; Munnich A
    Hum Genet; 1991 Dec; 88(2):153-6. PubMed ID: 1721894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperammonaemic encephalopathy after initiation of valproate therapy in unrecognised ornithine transcarbamylase deficiency.
    Oechsner M; Steen C; Stürenburg HJ; Kohlschütter A
    J Neurol Neurosurg Psychiatry; 1998 May; 64(5):680-2. PubMed ID: 9598692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ornithine transcarbamylase deficiency in a male: strict correlation between metabolic control and plasma arginine concentration.
    Wendel U; Wieland J; Bremer HJ; Bachmann C
    Eur J Pediatr; 1989 Jan; 148(4):349-52. PubMed ID: 2707281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver ultrastructure in mitochondrial urea cycle enzyme deficiencies and comparison with Reye's syndrome.
    Latham PS; LaBrecque DR; McReynolds JW; Klatskin G
    Hepatology; 1984; 4(3):404-7. PubMed ID: 6724509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amino acid and DNA analyses in a family with ornithine transcarbamylase deficiency.
    Hou JW; Wang TR
    J Formos Med Assoc; 1996 Feb; 95(2):144-7. PubMed ID: 9064003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The activity of carbamoyl-phosphate synthetase I and ornithine carbamoyltransferase (OCT) in the intestine and screening for OCT deficiency in the rectal mucosa.
    Matsushima A; Orii T
    J Inherit Metab Dis; 1981; 4(2):83-4. PubMed ID: 6790859
    [No Abstract]   [Full Text] [Related]  

  • 15. Ornithine transcarbamylase deficiency: enzyme studies on a further case and a method of diagnosis using plasma enzyme ratios.
    Gray RG; Black JA; Lyons VH; Pollitt RJ
    Pediatr Res; 1976 Nov; 10(11):918-23. PubMed ID: 980551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a cytogenetic deletion and of four novel mutations (Q69X, I172F, G188V, G197R) affecting the gene for ornithine transcarbamylase (OTC) in Spanish patients with OTC deficiency.
    Climent C; García-Pérez MA; Sanjurjo P; Ruiz-Sanz JI; Vilaseca MA; Pineda M; Campistol J; Rubio V
    Hum Mutat; 1999 Oct; 14(4):352-3. PubMed ID: 10502831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A carbamylphosphate synthetase deficiency with no detectable immunoreactive enzyme and no translatable mRNA.
    Graf L; McIntyre P; Hoogenraad N; Brown G; Haan EA
    J Inherit Metab Dis; 1984; 7(3):104-6. PubMed ID: 6438391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Partial ornithine transcarbamylase deficiency associated with recurrent hyperammonemia, lethargy and depressed sensorium.
    Oizumi J; Ng WG; Koch R; Shaw KN; Sweetman L; Velazquez A; Donnell GN
    Clin Genet; 1984 Jun; 25(6):538-42. PubMed ID: 6733950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA analysis of ornithine transcarbamylase deficiency.
    Wendel U; Wilichowski E; Schmidtke J; Bachmann C
    Eur J Pediatr; 1988 May; 147(4):368-71. PubMed ID: 2899508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ornithine transcarbamylase deficiency: ten new mutations and high proportion of de novo mutations in heterozygous females.
    Oppliger Leibundgut E; Liechti-Gallati S; Colombo JP; Wermuth B
    Hum Mutat; 1997; 9(5):409-11. PubMed ID: 9143919
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.